Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3351
VerifyMe
VRME
$9.38M
| $69.3K | ﹤0.01% |
92,000
-58,100
| -39% | -$41.4K |
|
|
AIFA
3352
All In FutureTech Alliance Inc
AIFA
$10.3M
| $68.6K | ﹤0.01% |
4,417
+917
| +26% | +$10.7K |
|
|
KORE
3353
DELISTED
KORE Group Holdings
KORE
| $68.5K | ﹤0.01% |
28,641
+800
| +3% | +$1.93K |
|
|
FORA
3354
DELISTED
Forian
FORA
| $67K | ﹤0.01% |
34,200
-1,400
| -4% | -$2.83K |
|
3355
System1
SST
$14.3M
| $66.5K | ﹤0.01% |
12,020
+740
| +7% | +$3.28K |
|
3356
CS Disco
LAW
$250M
| $66.4K | ﹤0.01% |
+15,200
| New | +$59.6K |
|
3357
Genelux
GNLX
$132M
| $65.1K | ﹤0.01% |
22,700
+3,400
| +18% | +$8.98K |
|
3358
Ocean Power Technologies
OPTT
$48.9M
| $65.1K | ﹤0.01% |
+137,069
| New | +$65K |
|
|
IPM
3359
Intelligent Protection Management Corp
IPM
$23.5M
| $64.4K | ﹤0.01% |
34,100
+3,500
| +11% | +$6.72K |
|
3360
Amtech Systems
ASYS
$268M
| $64.4K | ﹤0.01% |
14,500
+1,800
| +14% | +$7.03K |
|
3361
SOPHiA GENETICS
SOPH
$476M
| $64.2K | ﹤0.01% |
20,700
+600
| +3% | +$1.79K |
|
3362
Energous
WATT
$77.6M
| $63.8K | ﹤0.01% |
+7,797
| New | +$64.7K |
|
|
ZEPP
3363
Zepp Health
ZEPP
$66.4M
| $63.4K | ﹤0.01% |
23,824
| – | – |
|
3364
Syntec Optics
OPTX
$263M
| $61.8K | ﹤0.01% |
+46,100
| New | +$65.4K |
|
3365
Beyond Air
XAIR
$3.8M
| $61.7K | ﹤0.01% |
896
+405
| +82% | +$33K |
|
3366
Immuneering
IMRX
$267M
| $61.3K | ﹤0.01% |
+18,200
| New | +$31.2K |
|
|
ELEV
3367
DELISTED
Elevation Oncology
ELEV
| $60.9K | ﹤0.01% |
165,829
-481,471
| -74% | -$161K |
|
3368
FingerMotion
FNGR
$16.6M
| $59.5K | ﹤0.01% |
+29,300
| New | +$71.9K |
|
3369
ReWalk Robotics
LFWD
$20.3M
| $59.3K | ﹤0.01% |
7,659
+1,017
| +15% | +$15.6K |
|
|
KYNB
3370
Kyntra Bio
KYNB
$27.2M
| $59.3K | ﹤0.01% |
11,181
-8,070
| -42% | -$58.9K |
|
|
WOW
3371
DELISTED
WideOpenWest
WOW
| $58.9K | ﹤0.01% |
+14,500
| New | +$62.2K |
|
3372
Oxbridge Re Holdings
OXBR
$10.6M
| $57.8K | ﹤0.01% |
33,222
+10,067
| +43% | +$16.8K |
|
3373
Jasper Therapeutics
JSPR
$21M
| $57.7K | ﹤0.01% |
+10,400
| New | +$51.2K |
|
3374
CalciMedica
CALC
$15.8M
| $57.6K | ﹤0.01% |
36,000
+584
| +2% | +$1K |
|
|
HOOK
3375
DELISTED
HOOKIPA Pharma
HOOK
| $57.2K | ﹤0.01% |
45,570
+4,600
| +11% | +$5.68K |
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.